Asthma diagnosis and symptoms in an allergen immunotherapy trial treating grass pollen induced rhinoconjunctivitis

被引:0
|
作者
Hviid-Vyff, Bjarke [1 ,2 ]
Schmid, Johannes Martin [1 ,2 ]
Hoffmann, Hans Jurgen [1 ,2 ]
机构
[1] Aarhus Univ, Aarhus C, Denmark
[2] Aarhus Univ Hosp, Aarhus C, Denmark
关键词
D O I
10.1183/13993003.congress-2023.PA4749
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA4749
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Agreement of Efficacy Assessments for Five Grass Pollen Sublingual Immunotherapy (SLIT) Tablets in Children and Adolescents with Grass Pollen Rhinoconjunctivitis and with or without Mild Asthma.
    Wahn, U.
    Bauer, C.
    Agertoft, L.
    Melac, M.
    Le Gall, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S59 - S59
  • [32] Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience
    Didier, Alain
    Wahn, Ulrich
    Horak, Friedrich
    Cox, Linda S.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (10) : 1309 - 1324
  • [33] Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial
    Konradsen, Jon R.
    Grundstr, Jeanette
    Hellkvist, Laila
    Thi Anh Thu Tran
    Andersson, Niklas
    Gafvelin, Guro
    Kiewiet, M. B. Gea
    Hamsten, Carl
    Tang, Jiaqian
    Parkin, Rebecca V.
    Shamji, Mohamed H.
    Hedlin, Gunilla
    Cardell, Lars-Olaf
    van Hage, Marianne
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (03) : 1005 - +
  • [34] Safety of the 5-grass pollen sublingual tablet for the treatment of grass pollen-induced allergic rhinoconjunctivitis in subjects with and without asthma
    Zeldin, R. K.
    Cognet-Sice, J.
    Abiteboul, K.
    ALLERGY, 2015, 70 : 259 - 259
  • [35] Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis A Systematic Review and Meta-analysis
    Di Bona, Danilo
    Plaia, Antonella
    Leto-Barone, Maria Stefania
    La Piana, Simona
    Di Lorenzo, Gabriele
    JAMA INTERNAL MEDICINE, 2015, 175 (08) : 1301 - 1309
  • [36] Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper
    Pfaar, O.
    Bastl, K.
    Berger, U.
    Buters, J.
    Calderon, M. A.
    Clot, B.
    Darsow, U.
    Demoly, P.
    Durham, S. R.
    Gala'n, C.
    Gehrig, R.
    van Wijk, R. Gerth
    Jacobsen, L.
    Klimek, L.
    Sofiev, M.
    Thibaudon, M.
    Bergmann, K. C.
    ALLERGOLOGIE, 2018, 41 (09) : 386 - 399
  • [37] Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper
    Pfaar, O.
    Bastl, K.
    Berger, U.
    Buters, J.
    Calderon, M. A.
    Clot, B.
    Darsow, U.
    Demoly, P.
    Durham, S. R.
    Galan, C.
    Gehrig, R.
    Van Wijk, R. Gerth
    Jacobsen, L.
    Klimek, L.
    Sofiev, M.
    Thibaudon, M.
    Bergmann, K. C.
    ALLERGY, 2017, 72 (05) : 713 - 722
  • [38] Efficacy and safety of sublingual immunotherapy [SLIT] tablets in grass pollen rhinoconjunctivitis
    Didier, A
    Melac, M
    Combebias, A
    Andre, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (03) : 721 - 721
  • [39] Grass pollen allergen immunotherapy: Safety and efficacy profile
    Daboussi, S.
    Chaabane, M.
    Mhamdi, S.
    Saidane, A.
    Aichaouia, C.
    Ben Dhia, I. E.
    Toujani, S.
    Moatemri, Z.
    REVUE FRANCAISE D ALLERGOLOGIE, 2024, 64 (01):
  • [40] Prolonged effect of allergen sublingual immunotherapy to grass pollen
    Bozek, Andrzej
    Jakalski, Marek
    Jonska-Golus, Monika
    Filipowska-Gronska, Agata
    Jarzab, Jerzy
    Canonica, Giorgio Walter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (12) : 2842 - 2847